Navigation Links
bioMérieux Partners with Ultimate Labs to Bring Unprecedented Speed to Pathogen Identification for Food, Drug, and Cosmetic Manufacturers

St. Louis, MO (PRWEB) July 11, 2013

bioMérieux, a world leader in the field of in vitro diagnostics, is pleased to announce it has joined with Ultimate Labs, a leader in the safe production and quality control of food, drugs, and medical devices, to provide the industry with VITEK® MS - the most rapid mass spectrometry method available to detect microbial pathogens in food and pharmaceutical production.

VITEK MS, uses MALDI-TOF mass spectrometry technology to identify bacteria, yeast, and mold, offering significant time savings with respect to traditional identification methods. It is also extremely sensitive, providing a standard of accuracy above many of the current state-of-the art techniques.

“We are extremely pleased to bring this state-of-the-art technology to our customers,” said Kim Lim, CEO of Ultimate Labs. “Our clients adhere to strict safety and quality control regulations issued by governmental agencies such as the USDA and the FDA, and have to be compliant with industry standards. Also, they are eager to identify potential contaminants faster and to increase the sensitivity of their testing. The quantitative protein profiling provided by VITEK MS allows a greatly improved accuracy and time-to-results for our customers," Ms. Lim added. "For our clients where results impact products with short shelf-lives, the faster we can get results to them, the better.”

Bacterial and mold identification are crucial to confirm contaminations and to guide corrective actions in the production of consumable products made by pharmaceutical, cosmetic, and food manufacturers. With 50 years of experience in microbial identification, bioMérieux is the only microbiology company offering a mass spectrometry solution for industry needs. VITEK MS provides fast, flexible, and robust results, and can provide an identification of a microorganism’s genus and species in just a few minutes. As the world leader in microbiology, bioMérieux pairs VITEK MS system with the most comprehensive microbial database in the business.

“Reference laboratories today are striving to improve productivity and shorten their time-to-results,” said Pierre-Louis Thiney, Executive Director US Industry for bioMérieux. “Providing a fully integrated, rapid solution for microbial identification is a significant step in providing timely and accurate results to the customer.”

VITEK MS is available for industrial use and has been submitted for marketing clearance to the FDA for the clinical market. For more information on VITEK MS along with other bioMérieux industry technologies, please visit

About MALDI-TOF Mass Spectrometry

In the MALDI-TOF* process, the sample to be analyzed is mixed with another compound, called a matrix. The mixture is applied to a target slide, placed inside the instrument, and irradiated with a laser. The matrix absorbs the laser light and vaporizes, along with the sample, in the process gaining an electrical charge (ionization).

Electric fields then guide the ions into the flight tube, which separates them according to ‘weight’ (mass) and displays the results as a series of lines (spectrum) which correspond to different fragments that have broken away from the original molecule. By analyzing the pattern of fragments, it is possible to deduce the structure of the molecule.

VITEK MS takes this further by comparing the sample spectrum to an extensive database of spectra from bacterial species to allow the system to accurately identify the microorganism in question.

*Matrix Assisted Laser Desorption/Ionization Time-Of-Flight

About Ultimate Labs

Ultimate Labs is dedicated to helping save lives by providing environmental monitoring and microbial, water, and food testing to the pharmaceutical, biotechnology, medical device, and food industries. We assist in compliance understanding and risk assessment to help companies make better business decisions about product safety. Our unique approach is to provide tailored, problem-solving solutions to help you stay compliant or get back in compliance. For more information, call +1 866-932-9594 or visit

About bioMérieux

Pioneering Diagnostics

A world leader in the field of in vitro diagnostics for the past 50 years, bioMérieux is present in more than 150 countries through 41 subsidiaries and a large network of distributors. In 2012, revenues reached €1.57 billion with 87% of sales outside of France.

bioMérieux provides diagnostic solutions (reagents, instruments, software) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are used for diagnosing infectious diseases and providing high medical value results for cancer screening and monitoring and cardiovascular emergencies. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.

Additional information can be found at

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. bioMérieux to Feature Sepsis Solutions at New York Meeting of the American Society of Microbiology
2. Women With Older Partners More Often Admitted to Nursing Homes
3. University of Houston Graduate College of Social Work announces partnership with MD Anderson
4. Partnership provides inclusive workout
5. Global Cassava Partnership for the 21st Century (GCP21)
6. FDA clears test developed in partnership with VCU researcher
7. Cyber exercise partners help you go the distance
8. ACP-New York State Chapter partnership results in patient safety organization recognition
9. Partners with SwaddleDesigns
10. Candeo Partners with Catholic Church Organization to Release New Sexual Addiction Recovery Program
11. The Biochar Company Partners with Hawaii Biochar Products
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... For many X-rays taken ... for accurate interpretation by the radiologist. The marking utensils are so small, however, ... has found a way to alleviate this problem. , He developed the patent-pending ...
(Date:12/1/2015)... ... December 01, 2015 , ... Visage accelerates ... a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has announced they ... Society of North America (RSNA) 2015 annual meeting through December 3 in Chicago, ...
(Date:12/1/2015)... ... December 01, 2015 , ... Next ... selected as a finalist in this year’s Fierce Innovation Awards: Healthcare Edition, an ... was recognized as a finalist in the category of Digital Solutions for its ...
(Date:12/1/2015)... ... ... Lutronic, a leading innovator of aesthetic and medical laser and energy-based technology, announced ... the United States. Clarity is a Superior Dual Wavelength Platform which combines two ... platform that is easy to own and operate. , For over a decade, ...
(Date:12/1/2015)... ... December 01, 2015 , ... PYA’s ... Post-Affiliation Integration ,” addresses a main “pain point” for merging or aligning healthcare ... once a deal is signed. This quick-read guidance suggests that failing to ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 01, 2015 ... addition of the "2016 Europe ... E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, ... their offering. --> ... the "2016 Europe Enteric Disease ...
(Date:12/1/2015)... -- Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing ... that the company will present at the LD Micro Main ... Luxe Sunset Boulevard Hotel in Los Angeles, CA. ... will present on Thursday, December 3, at 9:00 am Pacific ... register at least 10 minutes prior to the start of ...
(Date:12/1/2015)... CytRx Corporation (NASDAQ: CYTR ), a ... announced that it has reached its enrollment target of ... clinical trial of aldoxorubicin in patients with previously treated ... completed in Q1 2016. The Phase 3 trial is a ... Assessment from the FDA at 79 sites in ...
Breaking Medicine Technology: